Ingenuity Canonical Pathways	AnalysisName	CC_ID	Timepoint	(-log p-value)	Ratio	z-score
4-1BB Signaling in T Lymphocytes	Coef.Sp_CC006xCC007_d12	CC(006x007)/F1	12	4.71	0.323	-3
Actin Cytoskeleton Signaling	Coef.Sp_CC006xCC007_d12	CC(006x007)/F1	12	8.87	0.184	-4
Actin Nucleation by ARP-WASP Complex	Coef.Sp_CC006xCC007_d12	CC(006x007)/F1	12	3.6	0.214	-1.897
Activation of IRF by Cytosolic Pattern Recognition Receptors	Coef.Sp_CC019xCC004_d4	CC(019x004)/F1	4	6.61	0.145	1
Activation of IRF by Cytosolic Pattern Recognition Receptors	Coef.Sp_CC019xCC004_d2	CC(019x004)/F1	2	5.53	0.129	0.707
Activation of IRF by Cytosolic Pattern Recognition Receptors	Coef.Sp_CC006xCC007_d7	CC(006x007)/F1	7	1.87	0.0645	-1
Activation of IRF by Cytosolic Pattern Recognition Receptors	Coef.Sp_CC006xCC007_d4	CC(006x007)/F1	4	5.16	0.113	0.378
Activation of IRF by Cytosolic Pattern Recognition Receptors	Coef.Sp_CC006xCC007_d12	CC(006x007)/F1	12	2.14	0.161	-1.265
Acute Myeloid Leukemia Signaling	Coef.Sp_CC006xCC007_d12	CC(006x007)/F1	12	4.06	0.187	-3.5
Acute Phase Response Signaling	Coef.Sp_CC019xCC004_d4	CC(019x004)/F1	4	1.44	0.0355	1
Acute Phase Response Signaling	Coef.Sp_CC006xCC007_d12	CC(006x007)/F1	12	3.1	0.136	-1.789
AMPK Signaling	Coef.Sp_CC006xCC007_d12	CC(006x007)/F1	12	2.45	0.122	-2.668
Angiopoietin Signaling	Coef.Sp_CC006xCC007_d12	CC(006x007)/F1	12	5.68	0.234	-1.155
Antioxidant Action of Vitamin C	Coef.Sp_CC006xCC007_d12	CC(006x007)/F1	12	2.5	0.146	1.069
Antiproliferative Role of Somatostatin Receptor 2	Coef.Sp_CC006xCC007_d12	CC(006x007)/F1	12	4	0.2	-3.464
Apoptosis Signaling	Coef.Sp_CC006xCC007_d12	CC(006x007)/F1	12	3.65	0.18	1.069
April Mediated Signaling	Coef.Sp_CC006xCC007_d12	CC(006x007)/F1	12	3.87	0.263	-2.53
B Cell Activating Factor Signaling	Coef.Sp_CC006xCC007_d12	CC(006x007)/F1	12	3.67	0.25	-3
B Cell Receptor Signaling	Coef.Sp_CC006xCC007_d12	CC(006x007)/F1	12	18.1	0.276	-4.814
Calcium Signaling	Coef.Sp_CC006xCC007_d12	CC(006x007)/F1	12	4.77	0.157	-3.742
Calcium-induced T Lymphocyte Apoptosis	Coef.Sp_CC006xCC007_d12	CC(006x007)/F1	12	8.3	0.303	-4.025
cAMP-mediated signaling	Coef.Sp_CC006xCC007_d12	CC(006x007)/F1	12	5.86	0.158	-2.694
Cardiac Hypertrophy Signaling	Coef.Sp_CC006xCC007_d7	CC(006x007)/F1	7	1.21	0.0298	-1.134
Cardiac Hypertrophy Signaling	Coef.Sp_CC006xCC007_d12	CC(006x007)/F1	12	7.96	0.174	-5.284
CD27 Signaling in Lymphocytes	Coef.Sp_CC006xCC007_d12	CC(006x007)/F1	12	3.3	0.212	-2.53
CD28 Signaling in T Helper Cells	Coef.Sp_CC006xCC007_d12	CC(006x007)/F1	12	15.3	0.298	-4.95
CD40 Signaling	Coef.Sp_CC006xCC007_d12	CC(006x007)/F1	12	8.41	0.282	-3.411
Cdc42 Signaling	Coef.Sp_CC006xCC007_d12	CC(006x007)/F1	12	3.97	0.15	-2.5
CDK5 Signaling	Coef.Sp_CC006xCC007_d7	CC(006x007)/F1	7	1.22	0.0404	0
CDK5 Signaling	Coef.Sp_CC006xCC007_d12	CC(006x007)/F1	12	2.25	0.141	-1.069
Cell Cycle: G1/S Checkpoint Regulation	Coef.Sp_CC019xCC004_d2	CC(019x004)/F1	2	1.86	0.0625	0
Cell Cycle: G1/S Checkpoint Regulation	Coef.Sp_CC006xCC007_d12	CC(006x007)/F1	12	4.21	0.219	0.302
Cell Cycle: G2/M DNA Damage Checkpoint Regulation	Coef.Sp_CC019xCC004_d4	CC(019x004)/F1	4	2.27	0.0816	1
Ceramide Signaling	Coef.Sp_CC006xCC007_d12	CC(006x007)/F1	12	3.93	0.183	-0.258
Chemokine Signaling	Coef.Sp_CC006xCC007_d12	CC(006x007)/F1	12	3.7	0.197	-3.207
CNTF Signaling	Coef.Sp_CC006xCC007_d12	CC(006x007)/F1	12	2.58	0.175	-2.714
Colorectal Cancer Metastasis Signaling	Coef.Sp_CC006xCC007_d12	CC(006x007)/F1	12	9.82	0.186	-3.507
Corticotropin Releasing Hormone Signaling	Coef.Sp_CC006xCC007_d12	CC(006x007)/F1	12	8.6	0.243	-4.146
CREB Signaling in Neurons	Coef.Sp_CC006xCC007_d12	CC(006x007)/F1	12	6.33	0.174	-5.385
CXCR4 Signaling	Coef.Sp_CC006xCC007_d12	CC(006x007)/F1	12	8.02	0.2	-3.413
Cyclins and Cell Cycle Regulation	Coef.Sp_CC006xCC007_d12	CC(006x007)/F1	12	1.48	0.128	-0.447
Death Receptor Signaling	Coef.Sp_CC019xCC004_d4	CC(019x004)/F1	4	1.36	0.0435	2
Death Receptor Signaling	Coef.Sp_CC019xCC004_d2	CC(019x004)/F1	2	2.66	0.0652	2.449
Death Receptor Signaling	Coef.Sp_CC006xCC007_d4	CC(006x007)/F1	4	1.67	0.0435	2
Death Receptor Signaling	Coef.Sp_CC006xCC007_d12	CC(006x007)/F1	12	3.48	0.174	-2.84
Dendritic Cell Maturation	Coef.Sp_CC006xCC007_d12	CC(006x007)/F1	12	7.51	0.184	-5.396
Dopamine-DARPP32 Feedback in cAMP Signaling	Coef.Sp_CC006xCC007_d12	CC(006x007)/F1	12	6.58	0.185	-4.041
EGF Signaling	Coef.Sp_CC006xCC007_d12	CC(006x007)/F1	12	4.52	0.221	-3.873
ErbB4 Signaling	Coef.Sp_CC006xCC007_d12	CC(006x007)/F1	12	3.63	0.194	-3.742
ERK/MAPK Signaling	Coef.Sp_CC006xCC007_d12	CC(006x007)/F1	12	5.12	0.156	-3.413
Estrogen-mediated S-phase Entry	Coef.Sp_CC006xCC007_d12	CC(006x007)/F1	12	2.4	0.25	0.447
Fc Epsilon RI Signaling	Coef.Sp_CC006xCC007_d12	CC(006x007)/F1	12	6.67	0.21	-3.545
Fcγ Receptor-mediated Phagocytosis in Macrophages and Monocytes	Coef.Sp_CC019xCC004_d4	CC(019x004)/F1	4	1.34	0.043	0
Fcγ Receptor-mediated Phagocytosis in Macrophages and Monocytes	Coef.Sp_CC006xCC007_d4	CC(006x007)/F1	4	1.65	0.043	1
Fcγ Receptor-mediated Phagocytosis in Macrophages and Monocytes	Coef.Sp_CC006xCC007_d12	CC(006x007)/F1	12	8.27	0.258	-3.674
FcγRIIB Signaling in B Lymphocytes	Coef.Sp_CC006xCC007_d12	CC(006x007)/F1	12	3.22	0.208	-3.317
FGF Signaling	Coef.Sp_CC006xCC007_d12	CC(006x007)/F1	12	2.63	0.156	-3.207
fMLP Signaling in Neutrophils	Coef.Sp_CC006xCC007_d12	CC(006x007)/F1	12	9.02	0.24	-4.914
G Beta Gamma Signaling	Coef.Sp_CC006xCC007_d12	CC(006x007)/F1	12	3.71	0.182	-3.051
GDNF Family Ligand-Receptor Interactions	Coef.Sp_CC006xCC007_d12	CC(006x007)/F1	12	3.93	0.197	-2.887
Glioblastoma Multiforme Signaling	Coef.Sp_CC006xCC007_d7	CC(006x007)/F1	7	1.5	0.0377	0
Glioblastoma Multiforme Signaling	Coef.Sp_CC006xCC007_d12	CC(006x007)/F1	12	8.45	0.208	-3.182
Glioma Invasiveness Signaling	Coef.Sp_CC006xCC007_d12	CC(006x007)/F1	12	3.21	0.186	-3.051
Glioma Signaling	Coef.Sp_CC019xCC004_d4	CC(019x004)/F1	4	1.67	0.0455	-2
Glioma Signaling	Coef.Sp_CC006xCC007_d7	CC(006x007)/F1	7	1.62	0.0455	-0.447
Glioma Signaling	Coef.Sp_CC006xCC007_d12	CC(006x007)/F1	12	8.69	0.245	-3.8
GM-CSF Signaling	Coef.Sp_CC006xCC007_d12	CC(006x007)/F1	12	4.14	0.205	-3.207
Growth Hormone Signaling	Coef.Sp_CC006xCC007_d12	CC(006x007)/F1	12	3.09	0.173	-3.051
Gα12/13 Signaling	Coef.Sp_CC006xCC007_d12	CC(006x007)/F1	12	5.37	0.185	-3.962
Gαi Signaling	Coef.Sp_CC006xCC007_d12	CC(006x007)/F1	12	4.42	0.175	0
Gαq Signaling	Coef.Sp_CC006xCC007_d12	CC(006x007)/F1	12	10.2	0.225	-4.116
Gαs Signaling	Coef.Sp_CC006xCC007_d12	CC(006x007)/F1	12	1.55	0.119	-2.309
HGF Signaling	Coef.Sp_CC006xCC007_d12	CC(006x007)/F1	12	5.79	0.2	-4.264
HMGB1 Signaling	Coef.Sp_CC006xCC007_d12	CC(006x007)/F1	12	4.21	0.165	-4.264
Huntington's Disease Signaling	Coef.Sp_CC019xCC004_d2	CC(019x004)/F1	2	1.21	0.029	1
Huntington's Disease Signaling	Coef.Sp_CC006xCC007_d12	CC(006x007)/F1	12	1.75	0.104	3.3
iCOS-iCOSL Signaling in T Helper Cells	Coef.Sp_CC006xCC007_d12	CC(006x007)/F1	12	14	0.295	-4.747
IGF-1 Signaling	Coef.Sp_CC006xCC007_d12	CC(006x007)/F1	12	2.79	0.151	-3.5
IL-1 Signaling	Coef.Sp_CC006xCC007_d12	CC(006x007)/F1	12	3.05	0.165	-3.742
IL-17A Signaling in Airway Cells	Coef.Sp_CC006xCC007_d12	CC(006x007)/F1	12	5.04	0.221	-3.638
IL-2 Signaling	Coef.Sp_CC006xCC007_d12	CC(006x007)/F1	12	3.61	0.203	-3.606
IL-22 Signaling	Coef.Sp_CC006xCC007_d12	CC(006x007)/F1	12	1.73	0.208	-1.342
IL-3 Signaling	Coef.Sp_CC006xCC007_d12	CC(006x007)/F1	12	6.47	0.241	-2.236
IL-6 Signaling	Coef.Sp_CC006xCC007_d12	CC(006x007)/F1	12	5.56	0.189	-4.379
IL-8 Signaling	Coef.Sp_CC006xCC007_d12	CC(006x007)/F1	12	8.13	0.188	-4.802
IL-9 Signaling	Coef.Sp_CC006xCC007_d12	CC(006x007)/F1	12	4.6	0.267	-3.317
ILK Signaling	Coef.Sp_CC006xCC007_d7	CC(006x007)/F1	7	1.56	0.0357	0
ILK Signaling	Coef.Sp_CC006xCC007_d12	CC(006x007)/F1	12	7.16	0.179	-3.656
iNOS Signaling	Coef.Sp_CC006xCC007_d12	CC(006x007)/F1	12	5.47	0.295	-2
Insulin Receptor Signaling	Coef.Sp_CC006xCC007_d12	CC(006x007)/F1	12	4.28	0.163	-2.711
Integrin Signaling	Coef.Sp_CC006xCC007_d12	CC(006x007)/F1	12	12.3	0.215	-5.427
Interferon Signaling	Coef.Sp_CC019xCC004_d4	CC(019x004)/F1	4	8.8	0.25	2.121
Interferon Signaling	Coef.Sp_CC019xCC004_d2	CC(019x004)/F1	2	7.43	0.222	2.121
Interferon Signaling	Coef.Sp_CC006xCC007_d4	CC(006x007)/F1	4	3.13	0.111	2
Interferon Signaling	Coef.Sp_CC006xCC007_d12	CC(006x007)/F1	12	1.53	0.167	-1.633
JAK/Stat Signaling	Coef.Sp_CC006xCC007_d12	CC(006x007)/F1	12	5.19	0.217	-3.3
Leptin Signaling in Obesity	Coef.Sp_CC006xCC007_d12	CC(006x007)/F1	12	5.03	0.212	-2.53
Leukocyte Extravasation Signaling	Coef.Sp_CC006xCC007_d4	CC(006x007)/F1	4	1.46	0.0286	-0.816
Leukocyte Extravasation Signaling	Coef.Sp_CC006xCC007_d12	CC(006x007)/F1	12	8.39	0.186	-4.352
LPS/IL-1 Mediated Inhibition of RXR Function	Coef.Sp_CC006xCC007_d12	CC(006x007)/F1	12	1.21	0.095	-0.378
LPS-stimulated MAPK Signaling	Coef.Sp_CC006xCC007_d12	CC(006x007)/F1	12	8.27	0.267	-4.146
Lymphotoxin β Receptor Signaling	Coef.Sp_CC006xCC007_d12	CC(006x007)/F1	12	5.93	0.254	-3.742
Macropinocytosis Signaling	Coef.Sp_CC006xCC007_d12	CC(006x007)/F1	12	4.73	0.21	-3.873
Melanocyte Development and Pigmentation Signaling	Coef.Sp_CC006xCC007_d12	CC(006x007)/F1	12	4.34	0.189	-3.638
MIF-mediated Glucocorticoid Regulation	Coef.Sp_CC006xCC007_d12	CC(006x007)/F1	12	1.7	0.182	0
Mouse Embryonic Stem Cell Pluripotency	Coef.Sp_CC006xCC007_d12	CC(006x007)/F1	12	4.2	0.179	-2.982
mTOR Signaling	Coef.Sp_CC006xCC007_d12	CC(006x007)/F1	12	2.18	0.116	-3.13
Neuregulin Signaling	Coef.Sp_CC006xCC007_d12	CC(006x007)/F1	12	2.73	0.159	-2.887
Neuropathic Pain Signaling In Dorsal Horn Neurons	Coef.Sp_CC006xCC007_d12	CC(006x007)/F1	12	6.45	0.211	-4.899
Neurotrophin/TRK Signaling	Coef.Sp_CC006xCC007_d12	CC(006x007)/F1	12	1.55	0.132	-3.162
NF-κB Signaling	Coef.Sp_CC019xCC004_d4	CC(019x004)/F1	4	1.33	0.0333	0.816
NF-κB Signaling	Coef.Sp_CC006xCC007_d7	CC(006x007)/F1	7	1.74	0.0389	-1.134
NF-κB Signaling	Coef.Sp_CC006xCC007_d4	CC(006x007)/F1	4	1.75	0.0333	0
NF-κB Signaling	Coef.Sp_CC006xCC007_d12	CC(006x007)/F1	12	6.55	0.178	-4.49
NGF Signaling	Coef.Sp_CC006xCC007_d12	CC(006x007)/F1	12	4.59	0.179	-3.71
Non-Small Cell Lung Cancer Signaling	Coef.Sp_CC006xCC007_d12	CC(006x007)/F1	12	5.68	0.234	-3.357
NRF2-mediated Oxidative Stress Response	Coef.Sp_CC006xCC007_d12	CC(006x007)/F1	12	3.35	0.135	-1.941
OX40 Signaling Pathway	Coef.Sp_CC006xCC007_d12	CC(006x007)/F1	12	1.85	0.135	-1.342
p38 MAPK Signaling	Coef.Sp_CC006xCC007_d12	CC(006x007)/F1	12	1.64	0.12	-1.604
p70S6K Signaling	Coef.Sp_CC006xCC007_d12	CC(006x007)/F1	12	4.32	0.168	-4.264
PAK Signaling	Coef.Sp_CC006xCC007_d12	CC(006x007)/F1	12	5.05	0.198	-3.13
Pancreatic Adenocarcinoma Signaling	Coef.Sp_CC006xCC007_d12	CC(006x007)/F1	12	4.53	0.178	-3.5
Paxillin Signaling	Coef.Sp_CC006xCC007_d12	CC(006x007)/F1	12	8.42	0.239	-3.411
PDGF Signaling	Coef.Sp_CC006xCC007_d12	CC(006x007)/F1	12	4.67	0.2	-2.828
PEDF Signaling	Coef.Sp_CC006xCC007_d12	CC(006x007)/F1	12	4.52	0.202	-3.5
Phospholipase C Signaling	Coef.Sp_CC006xCC007_d12	CC(006x007)/F1	12	14.6	0.224	-2.985
PI3K/AKT Signaling	Coef.Sp_CC006xCC007_d12	CC(006x007)/F1	12	3.29	0.153	-2.84
PKCθ Signaling in T Lymphocytes	Coef.Sp_CC006xCC007_d12	CC(006x007)/F1	12	10.7	0.25	-5.396
Production of Nitric Oxide and Reactive Oxygen Species in Macrophages	Coef.Sp_CC006xCC007_d12	CC(006x007)/F1	12	12.5	0.228	-4.217
Prolactin Signaling	Coef.Sp_CC006xCC007_d12	CC(006x007)/F1	12	4.59	0.205	-3.5
Protein Kinase A Signaling	Coef.Sp_CC006xCC007_d12	CC(006x007)/F1	12	7.83	0.146	-2.236
PTEN Signaling	Coef.Sp_CC019xCC004_d4	CC(019x004)/F1	4	1.54	0.042	1.342
PTEN Signaling	Coef.Sp_CC006xCC007_d4	CC(006x007)/F1	4	1.32	0.0336	2
PTEN Signaling	Coef.Sp_CC006xCC007_d12	CC(006x007)/F1	12	2.28	0.134	2.5
Rac Signaling	Coef.Sp_CC006xCC007_d12	CC(006x007)/F1	12	4.59	0.179	-4.146
RANK Signaling in Osteoclasts	Coef.Sp_CC006xCC007_d12	CC(006x007)/F1	12	8.18	0.248	-4.491
Regulation of Cellular Mechanics by Calpain Protease	Coef.Sp_CC006xCC007_d12	CC(006x007)/F1	12	1.48	0.14	-1
Relaxin Signaling	Coef.Sp_CC006xCC007_d12	CC(006x007)/F1	12	5.24	0.173	-4.146
Remodeling of Epithelial Adherens Junctions	Coef.Sp_CC006xCC007_d12	CC(006x007)/F1	12	3.34	0.191	-2.646
Renal Cell Carcinoma Signaling	Coef.Sp_CC006xCC007_d12	CC(006x007)/F1	12	4.73	0.21	-3.051
Retinoic acid Mediated Apoptosis Signaling	Coef.Sp_CC019xCC004_d2	CC(019x004)/F1	2	2.73	0.082	2.236
RhoA Signaling	Coef.Sp_CC006xCC007_d12	CC(006x007)/F1	12	2.55	0.139	-1.807
RhoGDI Signaling	Coef.Sp_CC006xCC007_d12	CC(006x007)/F1	12	5.47	0.168	4.041
Role of NANOG in Mammalian Embryonic Stem Cell Pluripotency	Coef.Sp_CC006xCC007_d12	CC(006x007)/F1	12	1.82	0.123	-3
Role of NFAT in Cardiac Hypertrophy	Coef.Sp_CC006xCC007_d7	CC(006x007)/F1	7	2.09	0.0417	-1.414
Role of NFAT in Cardiac Hypertrophy	Coef.Sp_CC006xCC007_d12	CC(006x007)/F1	12	9	0.198	-5.096
Role of NFAT in Regulation of the Immune Response	Coef.Sp_CC006xCC007_d12	CC(006x007)/F1	12	8.91	0.2	-5.657
Role of p14/p19ARF in Tumor Suppression	Coef.Sp_CC006xCC007_d12	CC(006x007)/F1	12	1.66	0.163	1.89
Role of Pattern Recognition Receptors in Recognition of Bacteria and Viruses	Coef.Sp_CC019xCC004_d4	CC(019x004)/F1	4	3.77	0.0657	0.816
Role of Pattern Recognition Receptors in Recognition of Bacteria and Viruses	Coef.Sp_CC019xCC004_d2	CC(019x004)/F1	2	3.76	0.0657	1.342
Role of Pattern Recognition Receptors in Recognition of Bacteria and Viruses	Coef.Sp_CC006xCC007_d7	CC(006x007)/F1	7	2.99	0.0584	-0.447
Role of Pattern Recognition Receptors in Recognition of Bacteria and Viruses	Coef.Sp_CC006xCC007_d4	CC(006x007)/F1	4	3.73	0.0584	1.342
Role of Pattern Recognition Receptors in Recognition of Bacteria and Viruses	Coef.Sp_CC006xCC007_d12	CC(006x007)/F1	12	4.02	0.161	-4.123
Role of PI3K/AKT Signaling in the Pathogenesis of Influenza	Coef.Sp_CC006xCC007_d12	CC(006x007)/F1	12	2.39	0.158	-2.887
Role of RIG1-like Receptors in Antiviral Innate Immunity	Coef.Sp_CC006xCC007_d12	CC(006x007)/F1	12	1.66	0.163	-2.449
SAPK/JNK Signaling	Coef.Sp_CC006xCC007_d12	CC(006x007)/F1	12	2.88	0.154	-3.873
Signaling by Rho Family GTPases	Coef.Sp_CC006xCC007_d12	CC(006x007)/F1	12	7.33	0.166	-4.644
Sperm Motility	Coef.Sp_CC006xCC007_d12	CC(006x007)/F1	12	4.64	0.176	-2.985
Sphingosine-1-phosphate Signaling	Coef.Sp_CC006xCC007_d7	CC(006x007)/F1	7	1.45	0.041	0.447
Sphingosine-1-phosphate Signaling	Coef.Sp_CC006xCC007_d12	CC(006x007)/F1	12	7.04	0.213	-2.041
STAT3 Pathway	Coef.Sp_CC019xCC004_d4	CC(019x004)/F1	4	1.68	0.0548	-2
STAT3 Pathway	Coef.Sp_CC006xCC007_d12	CC(006x007)/F1	12	2.08	0.151	-1.508
Tec Kinase Signaling	Coef.Sp_CC006xCC007_d12	CC(006x007)/F1	12	8.82	0.206	-4.95
Telomerase Signaling	Coef.Sp_CC006xCC007_d12	CC(006x007)/F1	12	2.58	0.144	-2.887
TGF-β Signaling	Coef.Sp_CC006xCC007_d12	CC(006x007)/F1	12	1.55	0.126	-1.897
Thrombopoietin Signaling	Coef.Sp_CC006xCC007_d12	CC(006x007)/F1	12	4.76	0.231	-2.84
TNFR1 Signaling	Coef.Sp_CC006xCC007_d12	CC(006x007)/F1	12	4.91	0.265	-2.496
TNFR2 Signaling	Coef.Sp_CC006xCC007_d12	CC(006x007)/F1	12	4.15	0.31	-2.121
Toll-like Receptor Signaling	Coef.Sp_CC019xCC004_d4	CC(019x004)/F1	4	1.66	0.0541	2
Toll-like Receptor Signaling	Coef.Sp_CC006xCC007_d4	CC(006x007)/F1	4	1.98	0.0541	1
Toll-like Receptor Signaling	Coef.Sp_CC006xCC007_d12	CC(006x007)/F1	12	2.98	0.176	-2.449
TREM1 Signaling	Coef.Sp_CC006xCC007_d12	CC(006x007)/F1	12	4	0.2	-3.357
TWEAK Signaling	Coef.Sp_CC006xCC007_d12	CC(006x007)/F1	12	2.85	0.235	-1.414
Type I Diabetes Mellitus Signaling	Coef.Sp_CC006xCC007_d12	CC(006x007)/F1	12	5.02	0.191	-3.606
Type II Diabetes Mellitus Signaling	Coef.Sp_CC006xCC007_d12	CC(006x007)/F1	12	5.56	0.189	-4.025
UVA-Induced MAPK Signaling	Coef.Sp_CC019xCC004_d4	CC(019x004)/F1	4	1.22	0.0392	1
UVA-Induced MAPK Signaling	Coef.Sp_CC019xCC004_d2	CC(019x004)/F1	2	1.79	0.049	1.342
UVA-Induced MAPK Signaling	Coef.Sp_CC006xCC007_d4	CC(006x007)/F1	4	1.52	0.0392	1
UVA-Induced MAPK Signaling	Coef.Sp_CC006xCC007_d12	CC(006x007)/F1	12	2.14	0.137	-3.606
UVB-Induced MAPK Signaling	Coef.Sp_CC006xCC007_d12	CC(006x007)/F1	12	2.92	0.182	-3.464
UVC-Induced MAPK Signaling	Coef.Sp_CC006xCC007_d12	CC(006x007)/F1	12	2.84	0.214	-2.333
VEGF Family Ligand-Receptor Interactions	Coef.Sp_CC006xCC007_d12	CC(006x007)/F1	12	4.81	0.205	-3.153
VEGF Signaling	Coef.Sp_CC006xCC007_d12	CC(006x007)/F1	12	6.08	0.214	-2.982
α-Adrenergic Signaling	Coef.Sp_CC006xCC007_d12	CC(006x007)/F1	12	6.12	0.23	-3.441